INDP - Indaptus Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

INDP is currently covered by 2 analysts with an average price target of $9.46. This is a potential upside of $7.35 (348.34%) from yesterday's end of day stock price of $2.11.

Indaptus Therapeutics's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of INDP is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for INDP is $12, Lowest price target is $8, average price target is $9.46.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 15-Apr-2024. First documented stock forecast 20-Oct-2021.

Best performing analysts who are covering INDP - Indaptus Therapeutics:

Raghuram Selvaraju Jason Mccarthy

Currently out of the existing stock ratings of INDP, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$9.65 (410.64%)

12

14 days ago

0/3 (0%)

$9.38 (358.02%)

Buy

8

$5.65 (240.43%)

4

5 months 23 days ago

0/3 (0%)

$5.32 (198.51%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INDP (Indaptus Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju has 3 price targets and 16 ratings on INDP

Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?

Raghuram Selvaraju with highest potential upside - $9.65

Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?

Jason Mccarthy with lowest potential downside - $5.65

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?